Sort
130,381 grants matching “hiv”
Understanding reservoir dynamics through analysis of viral decay processes
$1,573,078Robert F Siliciano · Johns Hopkins University · P01 · FY2025 · AI
Understanding reservoir dynamics through analysis of viral decay processes
$1,573,078Robert F Siliciano · Johns Hopkins University · P01 · FY2023 · AI
CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS
$1,572,864Debra Olesen · John Snow, Inc. · U65 · FY2008 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,572,818Courtney Hampton · Arkansas State Department Of Health · U62 · FY2013 · PS
Modeling affinity maturation at molecular resolution
$1,572,724Thomas B Kepler · Boston University Medical Campus · U19 · FY2017 · AI
Scripps NeuroAIDS Preclinical Studies (SNAPS)
$1,572,651Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2010 · MH
Natural History of HIV Infection In Injection Drug Users
$1,572,631Gregory D Kirk · Johns Hopkins University · R56 · FY2013 · DA
Clinical Research Correlatives Core
$1,572,539Kaska Wloka · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
SAN DIEGO AND SOUTHWESTERN PRIMARY INFECTION PROGRAM
$1,572,469University Of California San Diego · U01 · FY2000 · AI
Factors Influencing Genetic Transcription Initiation And Termination
$1,572,404Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
$1,572,287Susan Morgello · Icahn School Of Medicine At Mount Sinai · N01 · FY2024 · MH
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,572,218University Of Southern California · U01 · FY2001 · AI
Multitargeted Microbicide Combinations to Block HIV
$1,572,025Mount Sinai School Of Medicine Of Nyu · U19 · FY2005 · HD
Core A -Administrative Core
$1,571,658Jerome A. Zack · University Of California Los Angeles · P30 · FY2023 · AI
Early Events in KSVH Infection of Primary B-cells
$1,571,505Erle S Robertson · University Of Pennsylvania · P01 · FY2017 · CA
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta
$1,571,377Lindsay M. Wohlers · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2008 · AI
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1
$1,571,351Henry M. Jackson Fdn For The Adv Mil/Med · P01 · FY2001 · AI
Preventive Vaccines for HIV
$1,571,294Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Development of Gleevec for TB and TB/HIV
$1,571,205Daniel Kalman · Emory University · UH3 · FY2019 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,571,102Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2014 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,570,572Judd E Shellito · Lsu Health Sciences Center · P01 · FY2008 · HL
ADOLESCENT MEDICINE TRIALS UNIT AT CHOP
$1,570,476Childrens Hospital Of Philadelphia · U01 · FY2004 · HD
Juntos (Together): A community led approach to enhance to Covid-19 testing among vulnerable Latinos
$1,570,444Gregory M Lucas · Johns Hopkins University · R01 · FY2020 · DA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,570,414Beth Israel Medical Ctr (New York) · U01 · FY2003 · AI
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1
$1,570,350Henry M. Jackson Fdn For The Adv Mil/Med · P01 · FY2003 · AI